Navigation Links
Cambrex Reports Third Quarter 2009 Results
Date:11/3/2009

ng-term supply agreement.

Selling, General and Administrative Expenses in the third quarter 2009 were $9.3 million compared to $8.8 million in the same period last year. The increase is a result of higher legal fees and personnel costs partially offset by a favorable impact of foreign currency.

Research and Development ("R&D") Expenses were $2.0 million in the third quarter 2009 compared to $1.8 million in the third quarter 2008. The increase is primarily due to higher costs related to the development of new products and technology platforms.

Operating Profit increased to $5.6 million in the third quarter 2009 from $4.5 million in the third quarter 2008. Excluding Restructuring Expenses and Strategic Alternative Costs of $1.2 million recorded in 2008, Operating Profit decreased $0.1 million quarter over quarter. EBITDA was $11.0 million, or 19.0% of sales, compared to Adjusted EBITDA of $11.4 million, or 20.2% of sales last year. This decrease is due primarily to an unfavorable impact of foreign currency and higher administrative expenses mostly offset by higher gross margins as discussed above.

The Provision for Income Taxes totaled $1.6 million in the third quarter 2009. The effective tax rate was 34.8% in the third quarter 2009 compared to 9.8% in the third quarter 2008. The increase is due to changes in the geographic mix of pre-tax earnings, the enactment of reduced tax rates in Sweden and tax benefits related to the favorable resolution of certain tax matters in the three months ended September 30, 2008. The Company's effective tax rates have been and are expected to remain highly sensitive to the geographic mix of income due to the Company's inability to recognize tax benefits where there has been a recent history of losses, primarily in the U.S.

Net Income for the third quarter 2009 was $3.0 million or $0.10 per share compared to $2.8 million or $0.10 per share in the third quarter 2008. '/>"/>

SOURCE Cambrex Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Wins 2009 Silver Innovation Award
2. Cambrex to Announce Third Quarter 2009 Financial Results on November 3, 2009
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Spherix Reports Second Quarter Earnings
5. Tapestry Reports Second Quarter 2007 Results
6. Callisto Reports on Second-Quarter 2007 Milestones
7. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
8. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
9. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
10. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
11. Biopure Reports on Meeting with the FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... ,Agendia, a world leader in molecular cancer ... Administration (FDA) cleared its MammaPrint breast,cancer recurrence test ... cancer recurrence test available to patients and physicians. ... four clearances for MammaPrint, covering,all aspects of this ... FDA clearance, along with our recently obtained CMS ...
(Date:12/17/2009)... (OTC Bulletin Board: SCIE) disclosed today that its Chairman ... to shareholders: ,, As the end of the year ... recent closing of a $4.3 million round of equity ... our business performance as we head into 2010. We ... We are increasing our sales and marketing activities and ...
(Date:12/17/2009)... Protalix BioTherapeutics, Inc. (NYSE-Amex: PLX ) today ... President, Sales and Commercial Affairs. In this ... be responsible for all commercial activities, including pre-launch ... with the collaboration agreement between the Company and ... that emerge from the Company,s pipeline. Ms. ...
Breaking Medicine Technology:FDA Broadens Clearance for Agendia's MammaPrint(R) 2SpectraScience Releases Shareholder Newsletter 2SpectraScience Releases Shareholder Newsletter 3SpectraScience Releases Shareholder Newsletter 4SpectraScience Releases Shareholder Newsletter 5Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 2Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 3Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 4Digital divide 3A Psychologists suggest ways to include the aging population in the tech revolution 60698 1Digital divide 3A Psychologists suggest ways to include the aging population in the tech revolution 60698 2OU achieves 2410 million in stimulus grants for 33 projects on the Norman campus 10636 1OU achieves 2410 million in stimulus grants for 33 projects on the Norman campus 10636 2OU achieves 2410 million in stimulus grants for 33 projects on the Norman campus 10636 3Common plants can eliminate indoor air pollutants 60694 1Common plants can eliminate indoor air pollutants 60694 2
... April 27 The Villa Group is closely monitoring the ... appropriate steps to ensure the safety and health of all ... properties (located in Cabo San Lucas, Puerto Vallarta, and Nuevo ... the outbreaks have occurred. No cases have been reported in ...
... Men taking generic drugs may be more likely ... than if they were using branded medications, according to ... a study at the 104th Annual Scientific Meeting of ... for alpha blockers and 5-alpha reductase inhibitors (5-ARIs), two ...
Other Medicine Technology:The Villa Group Informs on Mexico Travel Plans in Wake of Swine Flu Outbreak 2Generic Substitutes Less Effective/Safe Than Branded Medications in Treating Lower Urinary Tract Symptoms 2
(Date:12/17/2009)... TROY, Mich., Dec. 17 CareTech Solutions ( ... and services provider for hospitals and health systems, was ... segment, in the 2009 Top 20 Best in ... report ranks the performance of vendors in ... and many others. ,, CareTech,s overall performance ...
(Date:12/17/2009)... Dec. 17 AlloSource, one of the nation,s ... allografts for use in surgical procedures and the world,s ... announced that is has been selected as a finalist ... Awards, in the Samaritan Institute category honoring non-profits. This ... has been selected as a finalist by the annual ...
(Date:12/17/2009)... (December 17, 2009) Researchers from the La Jolla Institute ... of the world,s most dangerous infectious diseases tuberculosis, ... million federally-funded set of projects seeking to make new ... The Institute received four project awards totaling $18.8 million ... (NIAID), part of the National Institutes of Health, to ...
(Date:12/17/2009)... Invites Personal Stories of Inspiration on How Exercise Has Helped, Healed, ... ... 17, 2009 -- The International Health, Racquet & Sportsclub Association (IHRSA) ... America, it is urging Americans of all ages and abilities to ... create a culture of movement in America wherein regular daily exercise ...
(Date:12/17/2009)... Science in Human Resource Development Degree Online , ... ... Open enrollment has begun for Villanova’s newly online HR ... whose busy schedules can’t accommodate a campus-based program. With the ... in March 2010, location is no longer a barrier to ...
Breaking Medicine News(10 mins):Health News:CareTech Solutions Named 2009 'Best in KLAS' for Extensive Information Technology Outsourcing for the Second Consecutive Year 2Health News:CareTech Solutions Named 2009 'Best in KLAS' for Extensive Information Technology Outsourcing for the Second Consecutive Year 3Health News:AlloSource Recognized for Exemplifying Ethics Amongst Colorado Non-Profits 2Health News:AlloSource Recognized for Exemplifying Ethics Amongst Colorado Non-Profits 3Health News:NIH awards La Jolla Institute $18.8 million for major infectious disease study 2Health News:NIH awards La Jolla Institute $18.8 million for major infectious disease study 3Health News:NIH awards La Jolla Institute $18.8 million for major infectious disease study 4Health News:NIH awards La Jolla Institute $18.8 million for major infectious disease study 5Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 2Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 3Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 4Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 5Health News:A World-Class HR Master's Degree Is Now Within Reach – 100% Online 2Health News:A World-Class HR Master's Degree Is Now Within Reach – 100% Online 3
... wins multi-million dollar, multi-year technology ... Medical Center, Biloxi, MS, HOUSTON, May 20 Shipcom ... announced today,that they have been selected by the Air Force ... across the Air Force Medical,Service and then pilot RFID systems ...
... their Prescription History, WALNUT CREEK, Calif., May ... ) announced today a new collaboration with,Google Health ... between,patients and providers. Working with Google, Longs will ... customers with the ability to import their,prescription information ...
... According to the 2000 census, Americans office workers spend ... desks or work stations. Many recent studies on job ... in office environments, often under artificial light in windowless ... , How can employers make office environments more conducive ...
... Six years ago,Senator Patty Murray (D-WA) first introduced ... funding in the research critically needed,to develop effective ... related diseases. Since 2002, the Mesothelioma Applied,Research Foundation ... stop the death and suffering and to get ...
... to Standard Therapy for Eradicating H. pylori , ... sequential and standard triple therapies in patients with ... that sequential therapy appears superior to standard triple ... , Authors say if further trials confirm these ...
... (Nasdaq: MLAB ) today reported record sales and net income ... -- Annual revenue increases 13% to a new record -- ... Annual net income increases 16% to a new record -- ... Fourth quarter operating income increases 7% to a new record, ...
Other Medicine News:Health News:US Air Force Medical Service Selects Shipcom Wireless for Major Healthcare RFID Contract 2Health News:US Air Force Medical Service Selects Shipcom Wireless for Major Healthcare RFID Contract 3Health News:US Air Force Medical Service Selects Shipcom Wireless for Major Healthcare RFID Contract 4Health News:Longs Drugs Partners With Google on the Launch of Google Health 2Health News:Greener offices make happier employees 2Health News:Fighting Cancer: Historic Anti-Asbestos Legislation Moving Forward With Support of Meso Foundation 2Health News:Fighting Cancer: Historic Anti-Asbestos Legislation Moving Forward With Support of Meso Foundation 3Health News:Fighting Cancer: Historic Anti-Asbestos Legislation Moving Forward With Support of Meso Foundation 4Health News:Mesa Labs Reports Record Year End Sales and Earnings 2Health News:Mesa Labs Reports Record Year End Sales and Earnings 3Health News:Mesa Labs Reports Record Year End Sales and Earnings 4Health News:Mesa Labs Reports Record Year End Sales and Earnings 5Health News:Mesa Labs Reports Record Year End Sales and Earnings 6
... VHD was the first ... bleeding after diagnostic and ... procedures. It is a ... approved for immediate sheath ...
... VasoSeal VHD was ... rapidly stop bleeding after ... and radiology procedures. It ... sealing device approved for ...
... collagen hemostat. FirstStop is a non-friable, non-woven ... characteristics. It can easily be cut to ... FirstStop products are not dispersed when wet ... hemostasis is achieved. As the collagen forms ...
InterVascular HemaCarotid Patch product line offers the vascular surgeon a complete range of knitted, collagen coated patches in a wide range of sizes for carotid endarterectomy and angioplasty witho...
Medicine Products: